Method for detecting fetal thalassemia pathogenic gene and kit
A technology for thalassemia and disease-causing genes, which is applied in biochemical equipment and methods, and microbial determination/inspection, etc., can solve the problems of PCR false negatives and the inability to further determine the existence of maternal mutations, and achieve the effect of small sample size
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2018-10-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of gene detection, in particular to a method and a kit for detecting fetal thalassemia-causing genes. Background technique
[0002] Thalassemia (referred to as thalassemia) is one of the high-incidence genetic diseases in the world. It is due to the mutation or deletion of human α, β-globin gene, which leads to the imbalance of α, β-globin peptide chain synthesis rate, which causes hemolysis. sexual anemia. The two common types of thalassemia are α-thalassemia and β-thalassemia, α-thalassemia-related genes are HBA2 and HBA1, and β-thalassemia-related genes are HBB. Thalassemia is concentrated in tropical and subtropical regions, mostly in Mediterranean countries, followed by the Middle East, India, Pakistan, Southeast Asia, southern China and North Africa. The United States is an immigrant country, and its incidence is also relatively high. The provinces south of the Yangtze River in my country are high-in...
Examples
Embodiment 1
[0044] Construction of embodiment 1 haplotype (i.e. haploid genotype)
[0045] (1) Thalassemia primer and probe design
[0046] Design region for α-thalassemia (chr16:60022-2233661): downstream (10Kb) + HBA gene + upstream (10Kb), and design region for β-thalassemia (chr11:3236690-7177304): downstream (10Kb) + HBB gene + upstream (10Kp), and then use the dbSNP database to screen out 195 α-thalassemia SNP sites and 275 β-thalassemia SNP sites. Among them, the SNP site screening conditions: the SNP site has MAF>=20% at the same time in the Thousand Genomes Chinese Southerners and Northerners database; the 100bp sequence above and below the SNP site is a specific region and has no homology on the genome; and 45 %<GC<70% SNP sites do not have 3 consecutive identical bases. According to the SNP sites screened above, the amplification primer pair was designed through the Ampliseq Designer website (https: / / www.ampliseq.com / login / login.action), and the Agilent SureDesign website (ht...
Embodiment 3
[0072] Embodiment 3 maternal genetic situation analysis
[0073] Based on the analysis of paternal inheritance, the analysis of maternal inheritance was carried out. Select the locus (MN) whose genotype is homozygous father (MM) and heterozygous mother (MN), and determine whether the maternal pathogenic haplotype is inherited according to RHDO-SPRT, wherein the SPRT curve is calculated according to the following formula:
[0074]
[0075] in,
[0076] Upper boundary and Lower boundary refer to the upper bound and the lower bound respectively. In this detection method, the inventor defines haplotype 1 as the upper bound, and defines haplotype 2 as the lower bound. Use the SPRT algorithm to calculate the sum of the sum of the variation frequencies of the selected sites corresponding to the depth. If the screened loci are all between the upper and lower bounds, then it is impossible to tell which haplotype the fetus has inherited from the mother; if one or more of the acc...
Embodiment 4
[0078] Example 4 Test results of 5 thalassemia families
[0079] (1) Thalassemia test results
[0080] Families 1-5 were detected by the method of Example 2, and the haplotype construction results of families 1-5 are shown in Table 3-7. According to Mendel's law of inheritance, combined with family sample phenotype and known mutation type information, the pathogenic mutation is associated with the haplotype (for example: the father's genotype is MN, the mother's genotype is MN, and the child's genotype is NN (M is the disease-causing locus, N is the normal locus. M and N represent the bases A, T, C, G), and the child has inherited the father's haplotype 1 and the mother's haplotype 1 respectively, then The father's pathogenic locus M is on haplotype 2, and the mother's pathogenic locus M is on haplotype 2). Table 8 shows the results of the association of pathogenic loci in the father and mother of families 1-5 with haplotypes.
[0081] Table 3 Haplotype construction results...